Resources

1
Sep

POSTER – Human primary mast cells as an advanced model for drug development

Home / Resources / Posters Poster Human primary mast cells as an advanced model for drug development Chenyan Wu1, Anthony David1, Anne Dalapa-Amana1, Catherine Marques1, Alexandra Ochando2, Lorna Santos2 and Nicolas Gaudenzio3 1Genoskin SAS, Toulouse, France, 2Genoskin Inc, Salem MA, USA, 3Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, France A
Read more
25
Aug

WEBINAR #16 – Neuroimmune circuits in allergic immunity

Top-level science through the eyes of an expert.Neuroimmune circuits in allergic immunityJoin us for the next session in Genoskin’s webinar series, where we explore how cutaneous sensory neurons may shape allergic inflammation, including neuroimmune signaling, type 2 immune responses, and potential mTORC1-dependent “neuroimmune training” following repeated allergen exposure. WATCH NOW Neuroimmune circuits in allergic immunity The skin is a densely
Read more
28
Jul

Mast cell depletion mechanisms: from biological rationale to human-relevant testing

Mast cell depletion mechanisms: From biological rationale to human-relevant testingWhy mast cells are important Mast cells are tissue-resident immune cells best known for their role in allergic reactions, but their function extends far beyond allergy. Located in barrier tissues such as the skin, airways, and gastrointestinal tract, they help detect environmental triggers, pathogens, tissue damage, and inflammatory signals. Through the
Read more
29
Jun

PRESS RELEASE – Genoskin Expands Access to Primary Human Mast Cells Across North America

Genoskin expands access to Primary Human Mast Cells across North AmericaPress release Genoskin is pleased to announce that its primary human mast cells will now be available to customers in North America, marking a key milestone in the company's commercial development. This launch gives pharmaceutical and biotechnology researchers faster and more direct access to predictive, human-relevant immune cells for drug
Read more
13
May

Genoskin at MPS 2026

Conferences & eventsThank you for meeting our amazing teamGenoskin at the MPS World Summit 2026Enabling preclinical drug development with ex vivo human skin platforms Genoskin was proud to participate in the MPS World Summit 2026, held in Washington, DC, one of the leading global events dedicated to advancing microphysiological systems (MPS) and human-relevant models for drug development. The summit brought
Read more
27
Apr

FACT SHEET – WoundSkin®: Advance your wound healing research

WoundSkin® FactsheetHuman ex vivo skin model to study wound healing & bacterial infectionWoundSkin® Factsheet: Advance Your Wound Healing Research Download the WoundSkin® factsheet to explore how a physiologically relevant, wounded human skin model can support your wound healing and infection research. Built on ex vivo human skin tissue, WoundSkin® preserves the full complexity of native skin, including immune responses, while
Read more